Global 3D Cell Culture and 3D Bioprinting Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global 3D Cell Culture and 3D Bioprinting Market Research Report 2024
3D cell culture refers to a technique in cell biology and tissue engineering where cells are grown or cultured in a three-dimensional environment that better mimics the natural conditions found in living organisms compared to traditional two-dimensional (2D) cell cultures.
3D bioprinting is an advanced additive manufacturing technology used in the field of regenerative medicine and tissue engineering. It involves the precise layer-by-layer deposition of biological materials (such as cells, growth factors, and biomaterials) to create three-dimensional structures that mimic human tissues and organs.
According to MRAResearch’s new survey, global 3D Cell Culture and 3D Bioprinting market is projected to reach US$ 4690.9 million in 2033, increasing from US$ 2060.8 million in 2022, with the CAGR of 12.8% during the period of 2023 to 2033.
Improved methods for growing and maintaining organoids, which are three-dimensional, miniature organs that closely mimic the structure and function of real organs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global 3D Cell Culture and 3D Bioprinting market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
3D Biotek LLC
Aspect Biosystems Ltd.
CELLINK
CN Bio Innovations Ltd.
Corning Incorporated
CYFUSE BIOMEDICAL K.K.
GeSiM
InSphero
Lonza
Merck KGaA
Organovo Holdings Inc.
REPROCELL Inc.
Thermo Fisher Scientific Inc.
ENVISIONTEC
Segment by Type
3D Cell Culture
3D Bioprinting
Cancer and Stem Cell Research
Drug Discovery and Toxicology Testing
Tissue Engineering and Regenerative Medicine
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The 3D Cell Culture and 3D Bioprinting report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
3D bioprinting is an advanced additive manufacturing technology used in the field of regenerative medicine and tissue engineering. It involves the precise layer-by-layer deposition of biological materials (such as cells, growth factors, and biomaterials) to create three-dimensional structures that mimic human tissues and organs.
According to MRAResearch’s new survey, global 3D Cell Culture and 3D Bioprinting market is projected to reach US$ 4690.9 million in 2033, increasing from US$ 2060.8 million in 2022, with the CAGR of 12.8% during the period of 2023 to 2033.
Improved methods for growing and maintaining organoids, which are three-dimensional, miniature organs that closely mimic the structure and function of real organs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global 3D Cell Culture and 3D Bioprinting market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
3D Biotek LLC
Aspect Biosystems Ltd.
CELLINK
CN Bio Innovations Ltd.
Corning Incorporated
CYFUSE BIOMEDICAL K.K.
GeSiM
InSphero
Lonza
Merck KGaA
Organovo Holdings Inc.
REPROCELL Inc.
Thermo Fisher Scientific Inc.
ENVISIONTEC
Segment by Type
3D Cell Culture
3D Bioprinting
Segment by Application
Cancer and Stem Cell Research
Drug Discovery and Toxicology Testing
Tissue Engineering and Regenerative Medicine
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The 3D Cell Culture and 3D Bioprinting report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source